FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2337567591> ?p ?o ?g. }

• W2337567591 endingPage "337" @default.
• W2337567591 startingPage "325" @default.
• W2337567591 abstract "Among neoplasms, brain tumors are particularly difficult to treat because of the partial immune privileged status of the brain and the presence of the blood brain barrier (Selmaj, 1996). Many details of progressive development of brain tumors remain unexplored and elucidation of consequent changes of the immune system with correlated cellular architecture and cell kinetics were the major objectives of the present course of investigations. Our studies have indicated that the primary resistance by the immune system to a growing tumor declines after a certain point, resulting in an immune suppressed state in a tumor bearing individual. The poor prognosis of malignant brain tumors with classical treatments like surgery, radiotherapy and chemotherapy has led to interest in immunotherapeutic protocols. In the present study, an attempt was made to determine the immunomodulatory and antitumor properties of a transmembrane glycopeptide of sheep red blood cells (SRBCs), known as S-LFA3 or T11TS. Young Druckray rat of both sexes aged 3-5 days were injected with N'-N'-ethyl nitrosourea (ENU) (i.p) to induce brain tumors and at 2,4,6,8 and 10 months of age were sacrificed for study of survival, tumor growth kinetics and immunological parameters like lymphocyte rosette formation, denoting CD2 - CD58 interactions and phagocytosis by peripheral macrophages and PMN hint at the changes during tumore development. In order to determine the immunomodulatory role of T11TS, 7 month old ENU induced animals and controls were injected with the compound (1 ml., i.p). The data obtained indicate that administration of T11TS results in increased survival of rats along with a decrease in growth kinetics of tumor cells to the normal level when compared to ENU induced animals of the same age. Pointers to mechanisms involving immunological investigations at the cellular level in these animals indicated improved lymphocyte function in terms of E-rosetting, augmented cytotoxicity and enhanced PMN and macrophage function in terms of phagocytosis. Finally histological examination showed complete reversal from the hyperplastic state to normal cellular homeostasis, indicating antitumor efficacy of T11TS, correlating very well with the data from survival and cell kinetic studies." @default.
• W2337567591 created "2016-06-24" @default.
• W2337567591 creator A5009811000 @default.
• W2337567591 creator A5060042359 @default.
• W2337567591 creator A5062740804 @default.
• W2337567591 creator A5065649387 @default.
• W2337567591 creator A5066419223 @default.
• W2337567591 creator A5074965166 @default.
• W2337567591 date "2002-01-01" @default.
• W2337567591 modified "2023-10-16" @default.
• W2337567591 title "Preclinical Changes in Immunoreactivity and Cellular Architecture during the Progressive Development of Intracranial Neoplasms and an Immunotherapeutic Schedule with a Novel Biological Response Modifier, the T11TS / S-LFA3." @default.
• W2337567591 cites W1501791324 @default.
• W2337567591 cites W1502513877 @default.
• W2337567591 cites W1505981109 @default.
• W2337567591 cites W1528827595 @default.
• W2337567591 cites W1554916919 @default.
• W2337567591 cites W1564678394 @default.
• W2337567591 cites W1565142449 @default.
• W2337567591 cites W1575613550 @default.
• W2337567591 cites W166179159 @default.
• W2337567591 cites W1775749144 @default.
• W2337567591 cites W1810482515 @default.
• W2337567591 cites W1893476731 @default.
• W2337567591 cites W1914508202 @default.
• W2337567591 cites W1963984598 @default.
• W2337567591 cites W1964264035 @default.
• W2337567591 cites W1966441019 @default.
• W2337567591 cites W1966454531 @default.
• W2337567591 cites W1969239731 @default.
• W2337567591 cites W1969931271 @default.
• W2337567591 cites W1971622541 @default.
• W2337567591 cites W1979746467 @default.
• W2337567591 cites W1983098040 @default.
• W2337567591 cites W1984971692 @default.
• W2337567591 cites W1987580232 @default.
• W2337567591 cites W1989672017 @default.
• W2337567591 cites W1996235568 @default.
• W2337567591 cites W1998053776 @default.
• W2337567591 cites W1999537874 @default.
• W2337567591 cites W2005909876 @default.
• W2337567591 cites W2008329439 @default.
• W2337567591 cites W2008688645 @default.
• W2337567591 cites W2016620180 @default.
• W2337567591 cites W2021474932 @default.
• W2337567591 cites W2048016883 @default.
• W2337567591 cites W2051222516 @default.
• W2337567591 cites W2061602566 @default.
• W2337567591 cites W2065552762 @default.
• W2337567591 cites W2071034146 @default.
• W2337567591 cites W2078240725 @default.
• W2337567591 cites W2082057360 @default.
• W2337567591 cites W2086195958 @default.
• W2337567591 cites W2088689097 @default.
• W2337567591 cites W2094012882 @default.
• W2337567591 cites W2095064585 @default.
• W2337567591 cites W2110424567 @default.
• W2337567591 cites W2137956266 @default.
• W2337567591 cites W2148571021 @default.
• W2337567591 cites W2150368859 @default.
• W2337567591 cites W2155740187 @default.
• W2337567591 cites W2159015045 @default.
• W2337567591 cites W2161494917 @default.
• W2337567591 cites W2163139226 @default.
• W2337567591 cites W2265187451 @default.
• W2337567591 cites W2277254873 @default.
• W2337567591 cites W2329536548 @default.
• W2337567591 cites W2406526239 @default.
• W2337567591 cites W2410025711 @default.
• W2337567591 cites W2412111105 @default.
• W2337567591 cites W2414801862 @default.
• W2337567591 cites W2416184420 @default.
• W2337567591 cites W2416705646 @default.
• W2337567591 cites W25659098 @default.
• W2337567591 cites W27277497 @default.
• W2337567591 cites W343231867 @default.
• W2337567591 cites W61614134 @default.
• W2337567591 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12716291" @default.
• W2337567591 hasPublicationYear "2002" @default.
• W2337567591 type Work @default.
• W2337567591 sameAs 2337567591 @default.
• W2337567591 citedByCount "4" @default.
• W2337567591 countsByYear W23375675912015 @default.
• W2337567591 crossrefType "journal-article" @default.
• W2337567591 hasAuthorship W2337567591A5009811000 @default.
• W2337567591 hasAuthorship W2337567591A5060042359 @default.
• W2337567591 hasAuthorship W2337567591A5062740804 @default.
• W2337567591 hasAuthorship W2337567591A5065649387 @default.
• W2337567591 hasAuthorship W2337567591A5066419223 @default.
• W2337567591 hasAuthorship W2337567591A5074965166 @default.
• W2337567591 hasConcept C142724271 @default.
• W2337567591 hasConcept C203014093 @default.
• W2337567591 hasConcept C2777701055 @default.
• W2337567591 hasConcept C2777761686 @default.
• W2337567591 hasConcept C2779130545 @default.
• W2337567591 hasConcept C502942594 @default.
• W2337567591 hasConcept C71924100 @default.
• W2337567591 hasConcept C86803240 @default.
• W2337567591 hasConcept C8891405 @default.

• next